Aurobindo Pharma Limited has informed the Exchange regarding a revised press release dated January 04, 2023, titled “Eugia Pharma receives USFDA approval for Azacitidine for Injection”…….
Subscribe To Our Free Newsletter |
Aurobindo Pharma Limited has informed the Exchange regarding a revised press release dated January 04, 2023, titled “Eugia Pharma receives USFDA approval for Azacitidine for Injection”…….
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!